Pharmacolog

Ver el organigrama con sus 10 ejecutivos principales

Biografías más buscadas en Pharmacolog

• Lars Gusch, Chief Executive Officer (until Apr 30 2024)
• Henrik Hjorth, Board Member
• Erik Hedlund, Chairman of the Board

Recientes movimientos de ejecutivos en Pharmacolog

• Anders Hedlund que es Board Member, ascenderá Interim Chief Executive Officer and Director el 1 de may.. de 2024  (noticia publicada el 5 de abril de 2024).
• Lars Gusch, Chief Executive Officer, abandonará la empresa el 30 de abr.. de 2024  (noticia publicada el 6 de marzo de 2024).

Crear su alerta
para seguir los movimientos de los ejecutivos en Pharmacolog.

Pharmacolog tiene 1.867 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacia

• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado el 23 de marzo de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado el 19 de marzo de 2024).
• Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).

Otros contactos sugeridos en el sector Farmacia

• Jean-Frédéric Paulsen - Executive Chairman of the Board en Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director en Dirk Rossmann
• Thierry Abribat - Chief Executive Officer en Amolyt Pharma

Saber más sobre el sector Farmacia >

Últimos comunicados de prensa de Pharmacolog

• Nolsterby Invest AB has increased its holding in Pharmacolog | Pharmacolog
• Pharmacolog announces the appointment of Anders Hedlund as interim CEO | Pharmacolog
• Pharmacolog provides update on new business direction and proposes name change | Pharmacolog
• NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL) | Pharmacolog
• Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million | Pharmacolog
• Pharmacolog announces upcoming change in management | Pharmacolog
• The subscription price for the exercise of warrants of series TO3 in Pharmacolog has been set at SEK 0.054 per share | Pharmacolog
• Pharmacolog divests part of its operations to RaySearch Laboratories AB | Pharmacolog
• The exercise period for warrants of series TO3 begins today | Pharmacolog
• Pharmacolog receives two DrugLog™ orders for installation in renowned hospitals in Europe. | Pharmacolog
• View more press releases Close

Redes sociales sobre Pharmacolog

• Pharmacolog en Wikipedia, Google News y Yahoo Finance
• Pharmacolog en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Lars Gusch

Llame a Pharmacolog al +46 ...

Ver el organigrama

Register to receive your alert

Señalar un error